Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

ClinicalTrials.gov ID: NCT00002359

Public ClinicalTrials.gov record NCT00002359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Regardless of Concomitant HIV Therapies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine the effect of HIV-1 immunogen (Remune) on AIDS-free survival, defined as the time prior to development of an AIDS-defining condition or death.

Study identification

NCT ID
NCT00002359
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
The Immune Response Corporation
Industry
Enrollment
3,000 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

United States locations

U.S. sites
54
U.S. states
27
U.S. cities
43
Facility City State ZIP Site status
Phoenix Body Positive Phoenix Arizona 85016 —
Ctr for Special Immunology Irvine California 92718 —
Jeffrey Goodman Special Care Clinic Los Angeles California 90028 —
Kraus Med Partners Los Angeles California 90036 —
Cedars Sinai Med Ctr Los Angeles California 90048 —
AIDS Community Research Consortium Redwood City California 94063 —
Whitman Walker Clinic Inc Washington D.C. District of Columbia 20009 —
Anderson Clinical Research Washington D.C. District of Columbia 20037 —
George Washington Univ Med Ctr Washington D.C. District of Columbia 20037 —
North Broward Hosp District Fort Lauderdale Florida 33316 —
Ctr for Special Immunology Miami Beach Florida 33140 —
The Coleman Institute North Miami Florida 33179 —
Clinical Pharmacology Services Tampa Florida 33617 —
AIDS Research Consortium of Atlanta Atlanta Georgia 30308 —
Rush Med Ctr Chicago Illinois 60612 —
Chicago AIDS Research Alliance Chicago Illinois 60657 —
Ctr for Special Immunology Chicago Illinois 60657 —
Community Hosp Indianapolis Indianapolis Indiana 46219 —
UKSM-W Med Practice Association Wichita Kansas 67214 —
Univ of Kentucky / Division of ID Research Lexington Kentucky 40536 —
JSI Research and Training Institute Boston Massachusetts 02210 —
Community Research Initiative of New England Brookline Village Massachusetts 02445 —
Providence Mercy Hosp Holyoke Massachusetts 01040 —
Wayne State Univ / WSU / DMC HIV / AIDS Program Detroit Michigan 48201 —
Henry Ford Hosp / Infectious Diseases Detroit Michigan 48202 —
Abbott Northwestern Hosp Minneapolis Minnesota 55407 —
Kansas City AIDS Research Consortium Kansas City Missouri 64111 —
Washington Univ / St Louis Connect Care St Louis Missouri 63108 —
Anderson Clinical Research New York New York 10016 —
St Luke's - Roosevelt Hosp Ctr / Div of Infect Dis New York New York 10019 —
Cornell Univ Med College New York New York 10021 —
Mount Sinai Med Ctr New York New York 10029 —
Dr Barbara Justice New York New York 10031 —
Community Health Network Rochester New York 14620 —
Bronx Lebanon Hosp Ctr The Bronx New York 10456 —
Nalle Clinic Charlotte North Carolina 28207 —
Univ of Cincinnati Med Ctr / Holmes Division Cincinnati Ohio 45267 —
Ohio State Univ / Division of Infectious Disease Columbus Ohio 43210 —
Univ of Oklahoma Oklahoma City Oklahoma 73117 —
The Research and Education Group Portland Oregon 97210 —
The Graduate Hosp Philadelphia Pennsylvania 19146 —
Anderson Clinical Research Pittsburgh Pennsylvania 15218 —
Mem Hosp of Rhode Island Pawtucket Rhode Island 02860 —
Med Univ of South Carolina Charleston South Carolina 29425 —
Vanderbilt Univ Med Ctr Nashville Tennessee 37212 —
Metroplex Clinical Research Ctr Dallas Texas 75235 —
Univ of Texas Med Branch Ctr for Clinical Studies Galveston Texas 77555 —
ONCOL Med Associates / PA Houston Texas 77027 —
Univ of Utah Med School / Clinical Trials Ctr Salt Lake City Utah 84108 —
Infectious Disease Physicians Inc Annandale Virginia 22003 —
Hampton Roads Med Specialists Hampton Virginia 23666 —
Eastern Virginia Med School Norfolk Virginia 23507 —
Novum Inc Seattle Washington 98104 —
Wisconsin AIDS Research Consortium Milwaukee Wisconsin 53203 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002359 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →